Paper42897296PubMed
Rare prostate cancer histologies: detection, characteristics and treatment.
Melão BVLA and 9 others. Nat Rev Urol, 2026.
Cite this record
ConductScience Library. Rare prostate cancer histologies: detection, characteristics and treatment. Papers, record 42897296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42897296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rare prostate cancer histologies: detection, characteristics and treatment.
- Journal
- Nat Rev Urol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-20
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References186
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32141804 | Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis. | J Urol | 2020 | https://conductscience.org/library/papers/32141804 | PubMed |
| 2 | 35221166 | Comparison of Typical Prostate Adenocarcinoma and Rare Histological Variant Prostate Cancer Showed Different Characteristics and Prognosis: A Surveillance, Epidemiology, and End Results Database Analysis. | Eur Urol | 2022 | https://conductscience.org/library/papers/35221166 | PubMed |
| 3 | 35758185 | WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. | Histopathology | 2022 | https://conductscience.org/library/papers/35758185 | PubMed |
| 4 | 28094848 | The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. | CA Cancer J Clin | 2017 | https://conductscience.org/library/papers/28094848 | PubMed |
| 5 | 36765754 | Prostate Cancer-PET Imaging Update. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765754 | PubMed |
| 6 | 36084769 | The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges. | Hum Pathol | 2023 | https://conductscience.org/library/papers/36084769 | PubMed |
| 7 | 2409826 | Mucinous adenocarcinoma of the prostate gland. | Am J Surg Pathol | 1985 | https://conductscience.org/library/papers/2409826 | PubMed |
| 8 | 38031818 | Recent Advances in Genitourinary Tumors: Updates From the 5th Edition of the World Health Organization Blue Book Series. | Arch Pathol Lab Med | 2024 | https://conductscience.org/library/papers/38031818 | PubMed |
| 9 | 36045292 | African-specific molecular taxonomy of prostate cancer. | Nature | 2022 | https://conductscience.org/library/papers/36045292 | PubMed |
| 10 | 31361600 | Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31361600 | PubMed |
| 11 | 35323352 | Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes. | Curr Oncol | 2022 | https://conductscience.org/library/papers/35323352 | PubMed |
| 12 | 33339136 | Neuroendocrine and Aggressive-Variant Prostate Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33339136 | PubMed |
| 13 | 30865487 | Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists. | Arch Pathol Lab Med | 2019 | https://conductscience.org/library/papers/30865487 | PubMed |
| 14 | 21502392 | Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. | Radiology | 2011 | https://conductscience.org/library/papers/21502392 | PubMed |
| 15 | 26900904 | Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. | AJR Am J Roentgenol | 2016 | https://conductscience.org/library/papers/26900904 | PubMed |
| 16 | 32459716 | The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. | Am J Surg Pathol | 2020 | https://conductscience.org/library/papers/32459716 | PubMed |
| 17 | 35965208 | The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. | Eur Urol | 2022 | https://conductscience.org/library/papers/35965208 | PubMed |
| 18 | 30280090 | The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature. | Front Oncol | 2018 | https://conductscience.org/library/papers/30280090 | PubMed |
| 19 | 29870405 | Evolution in Prostate Cancer Staging: Pathology Updates From AJCC 8th Edition and Opportunities That Remain. | Adv Anat Pathol | 2018 | https://conductscience.org/library/papers/29870405 | PubMed |
| 20 | 40112242 | State of the Art: Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer. | Am Soc Clin Oncol Educ Book | 2025 | https://conductscience.org/library/papers/40112242 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42897296
GET https://conductscience.org/api/papers/v1/42897296/references?page=2